The U.S. Federal Reserve is preparing to raise the asset thresholds that trigger stricter bank oversight, a change to limits set in 2019 that could reduce regulatory costs for regional lenders and potentially spur bank mergers while reigniting debate over financial stability and competition.
The Justice Department announced it will fast-track merger investigations by significantly reducing the amount of information requested from companies, marking a major shift in antitrust enforcement under the Trump administration.
The FDA and HHS are implementing sweeping reforms to speed up early-stage drug research in the United States, addressing concerns that pharmaceutical companies have increasingly moved clinical trials to countries like China and Australia. HHS Secretary Robert F. Kennedy Jr. announced the changes aimed at bringing investment back to the U.S.
